The incorporation tendency of fenethylline (FNT) and its metabolite into rat hair and the discrimination between FNT use and amphetamine (AP) use by hair analysis using gas chromatography-mass spectrometry with selected ion monitoring are described. After the intraperitoneal administrations of FNT to pigmented hairy rats (5 mg/kg/day, 10 days, n = 3), concentrations of FNT and its metabolite, AP, in the rat hair newly grown over 4 weeks were compared with area under the concentration versus time curves (AUCs) of the drugs in the rat plasma. The hair concentrations of FNT and AP were 52.0 + 1.4 and 4.9 • 0.6 ng/mg, whereas those of plasma AUCs were 55.9 • 23.1 and 22.3 • 4.9 pg. min/mL, respectively. The ratios of the hair concentrations to the AUCs of FNT and AP were 0.93 and 0.22, respectively. This suggests that FNT tends to he highly incorporated into hair from blood. The analytical method was applied to the determination of the metabolites in scalp hair of humans who were given FNT orally in multiple doses (50 rag/day, 3 days, n = 5) or in a single dose (50 rag/day, 1 day, n = 1). FNT and AP were detected at 0.51 • 0.23 and 0.35 * 0.12 ng/mg, respectively, in the proximal 1-cm hair segments from subjects given FNT orally for 3 days and 0.25 and 0.11 ng/mg, respectively, in the slngle-dose sample, in addition, it was found that the concentrations of FNT were 1.2 to 2.7 times greater than those of AP in the human hair samples, except for one sample, although FNT rapidly disappeared from the urine compared with AP. It was concluded that hair would be a good specimen for disclosure of drug history of FNT and for discrimination between FNT use and AP abuse. methyl theophylline and AP were major metabolites in the urine of three volunteers given 30 rng of FNT orally. They also demonstrated that carboxymethyi theophylline disappeared earlier than AP from the human urine and that only trace levels were detectable in urine at 24-48 h, whereas higher levels of AP were detectable over the same time interval.
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Several over-the-counter (OTC) drugs that are available in the United States, Europe, or Japan, such as deprenyl (3), benzphetamine (4, 5) , furfenorex (4, 5) , mefenorex (6) , fenproporex (7) , and FNT, have been reported to be metabolized to AP or methamphetamine (MA) or both in the body. From a forensic toxicological point of view, it is necessary to detect unique compounds derived from those drugs in biological specimens in order to distinguish legitimate drug use from illegal MA and AP use. However, it is sometimes difficult to detect these compounds in blood or urine because of their short half-lives.
In recent years, hair analysis for drugs has rapidly emerged as a useful tool for detecting and monitoring drugs over a long time period. Hair analysis provides useful information about individual drug history from a few days to years, whereas the information from blood and urine is limited by the duration of detection. We have already reported that the incorporation of drugs of abuse into hair mostly depends on their physicochemical properties (8, 9) and that parent compounds such as MA (10) , cocaine (11, 12) , and 6-acetylrnorphine (13) are more easily incorporated into hair than their polar metabolites. We have also demonstrated that parent compounds and their unique metabolites are definitely detected in the scalp hair of
Introduction
Fenethylline (FNT, 7-[2-(a-methylphenylethylamino)ethyi]-theophylline, Captagon| which has an amphetamine structure bound with theophylline via an alkyl chain (Figure 1 ), is used medically as a psychostimulant and antidepressant. FNT is extensively metabolized in animals and humans to amphetamine (AP) (1,2). Yoshimura et al. (2) showed that carboxy-* Author to whom correspondence should be addressed.
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Fenethylline (FNT) humans who orally took deprenyl or benzphetamine (14, 15) , although it is difficult to detect these compounds in the urine. Therefore, it was expected that AP-like OTC drugs would be detectable as parent compounds in hair.
In this study, we describe a gas chromatographic-mass spectrometric (GC-MS) method for the simultaneous identification and determination of FNT and AP in rat and human hair. The incorporation tendency of these drugs into the rat hair from the rat plasma was then investigated by the comparison of the hair concentrations and the area under the concentration versus time curves (AUCs) in the plasma. Furthermore, for the purpose of studying the disposition of FNT and AP into human hair and distinguishing between FNT use from AP abuse by hair analysis, the hair samples of humans who orally ingested FNT were analyzed.
Materials and Methods
Materials
FNT was synthesized from 7-(2-chloroethyl)theophylline and AP by the method of Kohlstaedt and Klinger (16) . AP (17) and desmethylbenzphetamine (norBZP) (15) were prepared according to our previous reports. The deuterated compound, 2-amino-1-phenylpropane-2,3,3,3-d4 (AP-d4), was synthesized by our method (10) .
Trifluoroacetic anhydride (TFAA) was purchased from Wako Chemicals (Tokyo, Japan). All other chemicals were of analytical reagent grade (Wako Chemicals).
Apparatus
GC-MS analysis was performed using a Hewlett Packard (Palo Alto, CA) 5890 series II GC equipped with 7673A autosampler and 5971 mass selective detector (MSD). The GC was equipped with a cross-linked methylsilicone fused-silica column TC-1 (20 m x 0.25-ram i.d., 0.25-1Jm film thickness, GL Sciences, Tokyo, Japan). The injection port temperature was 200~ (splitless mode), and helium was the carrier gas (5.5 psi head pressure; 1.16 mL/min flow rate). The oven temperature was programmed from 60~ (held for 0.5 rain) to 280~ at a rate of 20~
The transfer line was mainrained at 280~ Drugs in biological specimens were investigated by monitoring the following selected ions (dwell time, 50 ms): m/z 346, 319, 289, and 166 for trifluoroacetyl (TFA)-FNT; m/z 140 and 118 for TFA-AP; m/z 230 and 118 for TFA-norBZP; and m/z 144 for TFA-AP-d4.
Animal experiments
Before drug administration, the hair on the back of the rats was shaved with an electric shaver for animals (Daitoh Electric Machine, Tokyo, Japan). Male Dark Agouti (DA) pigmented rats, aged 5 weeks (100-120 g), were administered FNT-HCI intraperitoneally once a day (5 mg/kg) for 10 successive days (n --3). The newly grown hair was collected by the electric shaver 28 days after the first administration. Blood was collected at 5, 15, 30, 60, 120, and 360 min after injection with a capillary glass Table I tube from the orbital vein plexus on the day of the first administration. The blood was collected into a plastic tube containing heparin cooled in ice. The plasma samples were obtained by centrifugation at 10,000 • g for 3 rain and stored at -20~ until analysis. Plasma pharmacokinetic parameters were calculated as described previously (11) .
Human experiments
Three healthy male subjects (1, 2, 3) (black hair, 26-51 years) and three healthy female subjects (4, 5, 6) (black hair, 21-30 years) were given oral FNT-HCI either as a single dose of 50 mg (subject 6) or as multiple doses of 50 mg once a day for 3 days (subjects 1-5). Urine samples were collected from the three male subjects up to 24 h after the first dosage. Scalp hairs from the posterior vertex region were cut near the scalp 4 weeks (28 days) after the first dosage. A proximal segment (1 cm from the end of the root side) was used for this study.
Analytical methods
Internal standard (IS) aqueous solution. An IS solution was made by dissolving norBZP and AP-d4 in distilled water. The concentration of norBZP was 0.5 pg/mL, and the concentration of AP-d4 was i pg/mL.
Plasma. IS solution (100 IJL) was added to 100 IJL of plasma from a DA rat. The plasma in a small glass tube was extracted with 500 uL methylene chloride by vortex mixing under ammonium alkaline conditions. The organic phase was transferred into another tube and evaporated under a nitrogen stream after the addition of 100 pL of methanol-5N HC1 (20:1, v/v) to avoid the loss of amphetamine during evaporation. The residue was dissolved in 200 pL of TFAA--ethyl acetate (1:1, v/v) and heated at 60~ for 20 rain. The reaction solution was evaporated under a nitrogen stream at room temperature, and the residue was redissolved in 50 I~L of ethyl acetate. Two microliters of the ethyl acetate solution was automatically injected onto the GC-MS.
Urine. IS solution (200 pL) was added to human urine samples (0.5 mL). The solution was extracted, derivatized, and analyzed as described previously.
Hair. Hair samples were washed three times with 0.1% sodium dodecyl sulfate (SDS) under ultrasonication, then washed three times with water under the same conditions. The samples were dried under a nitrogen stream at room temperature and precisely weighed. The rat hair samples (10 mg) and human scalp hair samples (5.1-10.3 rag) were extracted with 2 mL of MeOH-SN HCI (20:1, v/v) mixed with 100 BL and 50 pL, respectively, of the IS solution for 1 h under ultrasonication and stored at room temperature overnight. The hair was removed, the filtrate was evaporated with a nitrogen stream, and the residue was dissolved in I mL of 0.1M phosphate buffer (pH 6.0). The solution was extracted, derivatized, and analyzed as described previously.
Quantitative analysis. The drug concentrations in the biological specimens were calculated using the peak-area ratios of the ions monitored for TFA-FNT (m/z 346) with TFA-norBZP (m/z 230) and for TFA-AP (m/z 140) with TFA-AP-d4 (m/z 144). The calibration curves for determination of FNT and AP were constructed by analyzing extracted and derivatized control 
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Journal of Analytical Toxicology, Vol. 21, July/August 1997 specimens spiked with the standard solutions of these drugs and the internal standards. The calibration curves for the drugs were linear over the concentration range of 10-2500 ng/mL in rat plasma or human urine and 0.1-50 ng/mg in hair with good correlation coefficients (r = 0.999).
Results and Discussion
Determination of FNT and AP in plasma, urine, and hair The simultaneous determination of FNT and AP in plasma, urine, and hair was studied with the liquid-liquid extraction method and with GC-MS-selected ion monitoring (SIM) using a stable isotope dilution method. As a result of our study on extraction, the liquid-liquid extraction with methylene chloride was much better in regard to the extraction efficiency and low background than solid-phase extraction (SPE) using Bond Elut Certify. Specifically, SPE gave very low recovery of FNT from biological samples. The electron-ionization (EI) mass spectrum of TFA-FNT is shown in Figure 2 . The ion fragments of m/z 346, 319, 289, and 166 were used for the confirmation of TFA-FNT.
Under the chromatographic conditions used, there were almost no interferences in either drugs or internal standards by any extractable endogenous materials in the control rat plasma, rat hair, or human urine. However, only the peak of FNT monitored with m/z 166 was overlapped by the peaks endogenous materials in the human hair. The coefficients of variation (CV) from analysis (n = 3) of the human scalp hair spiked with the standard solution of FNT and AP were 15.6 and 0.5%, respectively, at 5.0 ng/mg and 17.3 and 3.0% respectively, at 0.5 ng/mg. It is assumed that the large difference of the CV values between FNT and AP might be due to the characteristic differences between the target drug and the internal standard. The smaller CV values of AP suggested that the use of deuterated target drug brings about more precise analytical value than the use of the other internal standard.
Concentrations of FNT and AP in rat plasma
After the intraperitoneal administration of FNT-HC1 to rats at 5 mg/kg, the drug concentrations in the rat plasma were monitored using GC-MS. Time courses of the rat plasma concentrations of FNT and AP over 360 rain are shown in Figure 3 . The terminal plasma half-life for FNT was 12.4 rain, and FNT was detected in the plasma only until 120 rain after administration. The average peak plasma concentration of FNT (5 rain) was 15.7 times as much as that of AP (30 rain). The AUC values of FNT and AP in the rat plasma were 55.9 • 23.1 and 22.3 • 4.9 pg. min/mL, respectively (Table I) .
Drug concentrations in rat hair and incorporation rates of drugs into rat hair
GC-MS-SIM chromatograms of extracts (TFA derivatives) from the hair of the rat administered FNT are shown in Figure  4 . FNT and AP were detected in the rat hair at the concentrations of 52.0 • 1.4 and 4.9 • 0.6 ng/mg, respectively ( Table I) , showing that the concentration of FNT in the hair was more than 10 times higher than that of AP. We proposed (8, 9) that the ratio of drug concentration in hair to AUC in plasma (hair-AUC) is represented as an index indicating the incorporation tendency of drug into hair from plasma. According to our proposal, the hair-AUC ratios of FNT and AP were 0.93 and 0.22, respectively, as shown in Table I .
In our previous study (9) using more than 30 amphetamine analogues, we demonstrated that the hair-AUC ratios of the compounds containing the benzene or furan ring at the N-position ofAP (benzphetamine, clobenzorex, prenylamine, and furfenorex) were much higher than that of AP, which suggested that the benzene or furan ring acted positively to increase the halr-AUC ratio. In the case of FNT, its hair-AUC ratio was 0.93, which is about four times greater than that of AP. It was clear that the theophylline structure of the N-position of AP also affected its hair-AUC ratio very positively as well as the benzene or furan ring.
Time course of excretion of FNT and AP into human urine
The subjects' urine samples were collected from three male subjects given 50 mg of FNT up to 24 h after the first dosage, and the concentrations of drugs in the urine were monitored ( Figure 5 ).
FNT was detected in any urine samples only until 12 h after the dosage. AP was detected at more than 1.0 lag/mL in several urine specimens from two subjects even after the disappearance of FNT from urine. In such a case, it would be difficult to distinguish FNT use from AP use with urinalysis.
Detection of FNT and AP in human scalp hair after FNT intake
Human subjects were given FNT orally (50 mg/day) as a single dose (subject 6) or as multiple doses once a day for 3 days (subjects 1-5), and their scalp hair was collected 4 weeks after the first dose. The proximal 1-cm hair segments were analyzed using GC-MS-SIM. Figure 6 shows the SIM chromatograms of the TFA-defivatized extracts from the hair segments of subjects 1 and 3. FNT (0.17-0.73 ng/mg) and AP (0.25-0.55 ng/mg) were detected in hair segments of all subjects who took FNT for 3 days (Table II) . In the hair segments of the subject who took FNT as the single dose, FNT (0.25 ng/mg) and AP (0.11 ng/mg) were also detected. Moreover, it was found that the concentrations of FNT in the hair segments taken from subjects 1-5 (except for subject 2) were 1.2-2.7 times greater than those of AP even though FNT disappeared rapidly from the urine. From these results, it is thought that the criteria for discriminating FNT use from AP use would primarily depend on the detection of FNT and AP in hair. As shown in Table II , large individual differences regarding the drug concentrations in hair were found between the subjects with the multiple doses, which were up to 4.3 times larger for FNT and 2.2 times larger for AP. In addition, the ratios of FNT to AP varied among these five subjects. Moreover, there was no definite relationship between the dose and the drug concentration in hair when the results from the multiple dose and the single dose subjects in this study were compared.
Conclusion
Our results showed that hair is a good specimen for disclosure of drug history of FNT and discrimination between FNT use and AP use.
